Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
14<br />
BRITISH COLUMBIA<br />
TABLE 2. <strong>Clinical</strong> <strong>Trials</strong> Units, Centres, <strong>and</strong> Study Sites that Support <strong>Clinical</strong> <strong>Trials</strong> by<br />
Disease Area (cont’d)<br />
Facility<br />
(URL if available)<br />
Downtown Infectious<br />
Diseases Clinic<br />
(no URL)<br />
Vaccine Evaluation<br />
Centre CTU<br />
(www.bcchildrens.<br />
ca/Research/Vaccine-<br />
EvaluationCentre)<br />
Women & Family<br />
HIV Centre (no URL)<br />
Pulmonary<br />
James Hogg iCAP-<br />
TURE Centre<br />
Pacific Lung Centre<br />
(www.pacificlung.<br />
com)<br />
The Lung Centre<br />
(http://lungcentre.<br />
vch.ca/)<br />
<strong>Clinical</strong> <strong>Trials</strong><br />
Disease Focus<br />
Types<br />
of<br />
<strong>Trials</strong>*<br />
Annual<br />
Patient<br />
Accrual<br />
Hospital/<br />
Agency<br />
(Health<br />
Authority)*<br />
Investigators<br />
Mainly HIV <strong>and</strong> HCV II, III, IV 40 VGH (VCH) • Conway, Brian<br />
• Alenezi, Osamah<br />
• Reynolds, Robert<br />
Various infectious<br />
diseases<br />
Therapy, vaccines,<br />
<strong>and</strong> diagnostic/<br />
prognostic biomarkers<br />
in pregnant<br />
women, infants,<br />
children, <strong>and</strong> youth<br />
See above under<br />
“Cardiology” for<br />
details<br />
E.g. chronic obstructive<br />
pulmonary<br />
disease (bronchitis<br />
<strong>and</strong> emphysema),<br />
interstitial pulmonary<br />
fibrosis, chronic<br />
cough, cystic fibrosis,<br />
asthma<br />
E.g., asthma,<br />
emphysema,<br />
chronic bronchitis,<br />
bronchiectasis, lung<br />
cancer, occupational<br />
<strong>and</strong> environmental<br />
lung diseases, sarcoidosis,<br />
pnuemonia,<br />
tuberculosis, pulmonary<br />
hypertension<br />
<strong>and</strong> interstitial lung<br />
disease<br />
II, III, IV<br />
Not<br />
applicable<br />
BCCH (PHSA)<br />
• Scheifele, David<br />
• Dobson, Simon<br />
• Kollmann, Tobias<br />
• Bettinger, Julie<br />
• Sauve, Laura<br />
N/A N/A BCCH (PHSA) • Burdge, David<br />
• Forbes, John<br />
(Jack)<br />
II, III, IV N/A St Paul’s<br />
(Providence)<br />
• 11 investigators<br />
as listed in Appendix<br />
1<br />
II, III, IV 140 VGH (VCH) • 16 investigators<br />
as listed in Appendix<br />
1<br />
Contact<br />
Tossonian, Harout.<br />
Research Manager. T:<br />
604-642-6429 x 304.<br />
tossonian@exchange.<br />
ubc.ca.<br />
Bjornson, Gordean.<br />
T: 604-875-2422. gbjornson@cw.bc.ca.<br />
Forbes, John (Jack).<br />
Medical Director. T:<br />
604-875-2212. jforbes@<br />
cw.bc.ca.<br />
Tel: 604 806-9465. info@<br />
pacificlung.com.<br />
Tom, Freda. <strong>Clinical</strong> <strong>Trials</strong><br />
Coordinator.<br />
T: 604-875-4111 x<br />
67916.<br />
Freda.Tom@vch.ca.
Change language